Question Everything. See who's reporting it.

FDA approves Abbott's first dual-monitoring glucose and ketone device

Source: The Hindu

The story in brief

The FDA authorized Abbott's Libre Duo 10 Day device, the first to continuously monitor both ketone and glucose levels in diabetes patients. It provides real-time trends and automatic alerts to help detect rising ketones before DKA emergencies. The device, designed for a 10-day wear period for people aged 2 and older, integrates with the Libre app and is expected to work with insulin pumps from Insulet and Tandem in 2027.

NEWXFree on Android and iPhone. Open in NEWX